Skip to main content
. 2022 Apr 6;13:857932. doi: 10.3389/fphar.2022.857932

FIGURE 1.

FIGURE 1

The experimental schema and representative HPLC chromatogram of BCD. (A) POI mouse model development and treatment protocol. (B) HPLC analysis of BCD: Mobile phase was acetonitrile/ultrapure water (containing 0.1% phosphoric acid) gradient for 60 min with a flow of 1 ml/min. Peaks: 1. peoniflorin, 2. ferulic acid, 3. typhaneoside, 4. hyperoside, 5. isorhamnetin-3-O-neohesperidoside, 6. specnuezhenide, 7. cyasterone and 8. asperosaponin VI.